Thyroid · 2012 · 17 citations · 34 references
MedicineEndocrinologyOncologyCarcinogenesisMolecular OncologyNeoplasiaAngiogenesisAngiogenesis In CancerIodine DeficiencyIodine NutritionThyroid CancerThyroid EndocrinologyAngiogenic ResponseDietary Iodine IntakeHypoxia-inducible Factor ActivationHypoxia-inducible Factor SignalingHypoxia-inducible SignalingReactive Oxygen Species SignalingVascular Endothelial Growth FactorVascular Endothelial Growth Factor Signaling
BACKGROUND: In the thyroid, iodine deficiency (ID) induces angiogenesis via a tightly controlled reactive oxygen species (ROS)-hypoxia inducible factor-1 (HIF-1)-vascular endothelial growth factor (VEGF) dependent pathway (ROS-HIF-VEGF). Deficient iodine intake may be associated with increased thyroid cancer incidence. The hypothesis of this work is to test whether ID affects the angiogenic processes in thyroid malignant cells by altering the ROS-HIF-VEGF pathway. METHODS: Goiters were obtained in RET/PTC3 transgenic and wild-type (wt) mice and ID was induced in three thyroid carcinoma cell lines (TPC-1, 8305c, and R082-w1). Thyroid blood flow, VEGF mRNA and protein, and HIF-1α protein expression were measured. The role of HIF-1 and of ROS was assessed using echinomycin and N-acetylcysteine (NAC), respectively. RESULTS: The goitrogen treatment increased the thyroid blood flow in wt and RET/PTC3 mice. Compared with wt mice, basal VEGF expression was higher in RET/PTC3 mice and increased with goitrogen treatment. In the three cell lines, ID induced marked increases in VEGF mRNA, and moderate increases in HIF-1α protein expression that were not transient as in normal cells. ID-induced VEGF mRNA expression was fully (8305c), partially (TPC-1), or not (R082-w1) blocked by echinomycin. NAC had no effect on ID-induced VEGF mRNA and HIF-1α protein expression in the three cell lines. CONCLUSIONS: ID induces a long lasting angiogenic phenotype in thyroid cancer cells that occurs through VEGF induction via a pathway partially mediated by HIF-1, but not by ROS. These results suggest that, in contrast with normal cells, ID-induced angiogenesis in cancer cells occurs via alternative and likely less controlled routes, thereby leading to uncontrolled growth.
34
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
Louise Davies, H. Gilbert Welch · JAMA · 2006 · 3.4K citations
Alicia Antonelli-Orlidge, K.B. Saunders, Sandra R. Smith et al. · Proceedings of the National Academy of Sciences · 1989 · 760 citations · Full text
Rebecca E. Schweppe, Joshua Klopper, Christopher Korch et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 565 citations · Full text
Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity
Dehe Kong, Eun‐Jung Park, Andrew G. Stephen et al. · Cancer Research · 2005 · 513 citations · Full text
Medicine, Oncology, Pharmacology +10